![Filip Borgions](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Filip Borgions
Directeur Technique/Scientifique/R&D chez
ARGENX SE
Profil
Filip Borgions currently works at argenx SE, as Chief Technology Innovation Officer.
Dr. Borgions also formerly worked at Thrombogenics, Inc., as Principal.
Dr. Borgions received his undergraduate degree and doctorate degree from Katholieke Universiteit Leuven.
Postes actifs de Filip Borgions
| Sociétés | Poste | Début |
|---|---|---|
| ARGENX SE | Directeur Technique/Scientifique/R&D | 01/01/2015 |
Anciens postes connus de Filip Borgions
| Sociétés | Poste | Fin |
|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Corporate Officer/Principal | - |
Formation de Filip Borgions
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
